You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fibroblast growth factor receptor 3 alterations

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urothelial Carcinoma Trial in Shanghai (AZD4547, Tislelizumab)

Recruiting
  • Urothelial Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 8, 2023

Bladder Transitional Cell Carcinoma, Bladder Cancer, Fibroblast Growth Factor Receptor Trial (Infigratinib)

Withdrawn
  • Bladder Transitional Cell Carcinoma
  • +2 more
  • (no location specified)
Aug 8, 2022

Tumor Trial in China, Korea, Republic of, Taiwan (Erdafitinib)

Active, not recruiting
  • Neoplasm
  • Beijing, China
  • +5 more
Jan 31, 2023

Locally Advanced Gastrointestinal Stromal Tumor, Locally Advanced Sarcoma, Metastatic Gastrointestinal Stromal Tumor Trial in

Recruiting
  • Locally Advanced Gastrointestinal Stromal Tumor
  • +7 more
  • Biopsy
  • +4 more
  • Duarte, California
  • +17 more
Feb 2, 2023

Advanced or Recurrent Solid Tumors, FGFR Gene Alterations Trial in Japan (E7090)

Recruiting
  • Advanced or Recurrent Solid Tumors
  • FGFR Gene Alterations
  • Aoba-ku, Sendai, Miyagi, Japan
  • +4 more
May 9, 2022

Glioma, High Grade Glioma, Pontine Tumors Trial in Ann Arbor (Dasatinib, Everolimus)

Terminated
Has Results
  • Glioma
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Cancer Center
Sep 26, 2022

HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

Recruiting
  • HR+/HER2- Advanced Breast Cancer
  • Targeted Therapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Aug 1, 2023

Breast Tumors Trial in Chuo Ku, Koto-Ku (H3B-6545, Antihistamine)

Active, not recruiting
  • Breast Neoplasms
  • Chuo Ku, Japan
  • +1 more
Dec 19, 2022

Solid Tumours Trial in Worldwide (Debio1347 (CH5183284))

Terminated
  • Solid Tumours
  • Debio1347 (CH5183284)
  • Boston, Massachusetts
  • +7 more
Sep 8, 2020

Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation Trial in Canton (TAS6417)

Recruiting
  • Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
  • Canton, Ohio
    Gabrail Cancer and Research Center
Jul 25, 2023

Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Marietta, East Brunswick (Sacituzumab

Recruiting
  • Locally Advanced or Unresectable Metastatic Breast Cancer
  • Stage IV Breast Cancer
  • Sacituzumab Govitecan-hziy
  • +3 more
  • Marietta, Georgia
  • +1 more
Apr 21, 2023

Squamous-cell NSCLC Trial in Switzerland (Rogaratinib)

Active, not recruiting
  • Squamous-cell Non-small Cell Lung Cancer
  • Baden, Switzerland
  • +10 more
Jan 20, 2022

Breast Cancer Trial in Orange City (ARV-471 (PF-07850327), Palbociclib, Letrozole)

Recruiting
  • Breast Cancer
  • ARV-471 (PF-07850327)
  • +2 more
  • Orange City, Florida
    Mid Florida Hematology and Oncology Center
Jun 8, 2023

Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer Trial (HER3-DXd)

Available
  • Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer
  • (no location specified)
Oct 17, 2023

Primary Breast Cancer Trial (SPECT)

Not yet recruiting
  • Primary Breast Cancer
  • (no location specified)
Jun 19, 2023

Circulating Tumour DNA Testing in Assessing for Alterations of

Recruiting
  • Colorectal Cancer
    • Singapore, Singapore
      National University Hospital
    Sep 28, 2021

    Recurrent/Advanced Gastric Cancer Trial in Seoul (Chemotherapy)

    Not yet recruiting
    • Recurrent/Advanced Gastric Cancer
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Aug 22, 2022

    Bladder Cancer Trial in Indianapolis, Baltimore, Rockledge (Dovitinib)

    Terminated
    Has Results
    • Bladder Cancer
    • Indianapolis, Indiana
    • +2 more
    Jul 7, 2022

    Metastatic Breast Cancer, FGFR 1 High Amplification, FGFR2 Amplification Trial in Worldwide (Futibatinib, Futibatinib plus

    Recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Phoenix, Arizona
    • +36 more
    Jan 27, 2023

    Pre-frail Elderly Trial in Jakarta (Cholecalciferol, Placebo)

    Completed
    • Pre-frail Elderly
    • Jakarta, DKI Jakarta, Indonesia
      Cipto Mangunkusumo General Hospital
    Jan 25, 2023

    Breast Cancer Trial in Shanghai (HS-10352 combined with fulvestrant (Stage 1), HS-10352 combined with fulvestrant (Stage 2))

    Recruiting
    • Breast Cancer
    • HS-10352 combined with fulvestrant (Stage 1)
    • HS-10352 combined with fulvestrant (Stage 2)
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Aug 15, 2022

    Advanced Solid Tumor Trial in Worldwide (Erdafitinib)

    Recruiting
    • Advanced Solid Tumor
    • Tucson, Arizona
    • +199 more
    Jan 27, 2023

    Breast Cancer Female Trial in Tomsk ([99mTc]Tc-G3-(G3S)3C)

    Enrolling by invitation
    • Breast Cancer Female
    • Tomsk, Russian Federation
      Olga
    Jun 19, 2023

    Metastatic Breast Cancer Trial in Dallas (DB-1303, Capecitabine, Paclitaxel)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Dallas, Texas
      Texas Oncology - Baylor Charles A. Sammons Cancer Center
    Aug 25, 2023

    Breast Tumors, Breast Cancer, Adenocarcinomas Trial run by the NCI (AdHER2/neu DC Vaccine)

    Completed
    Has Results
    • Breast Neoplasms
    • +3 more
    • Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER)2/neu Dendritic Cell (DC) Vaccine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 12, 2022